Uganda's "EID Systems Strengthening" model produces significant gains in testing, linkage, and retention of HIV-exposed and infected infants: An impact evaluation.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
30
08
2020
accepted:
20
01
2021
entrez:
4
2
2021
pubmed:
5
2
2021
medline:
3
8
2021
Statut:
epublish
Résumé
A review of Uganda's HIV Early Infant Diagnosis (EID) program in 2010 revealed poor retention outcomes for HIV-exposed infants (HEI) after testing. The review informed development of the 'EID Systems Strengthening' model: a set of integrated initiatives at health facilities to improve testing, retention, and clinical care of HIV-exposed and infected infants. The program model was piloted at several facilities and later scaled countrywide. This mixed-methods study evaluates the program's impact and assesses its implementation. We conducted a retrospective cohort study at 12 health facilities in Uganda, comprising all HEI tested by DNA PCR from June 2011 to May 2014 (n = 707). Cohort data were collected manually at the health facilities and analyzed. To assess impact, retention outcomes were statistically compared to the baseline study's cohort outcomes. We conducted a cross-sectional qualitative assessment of program implementation through 1) structured clinic observation and 2) key informant interviews with health workers, district officials, NGO technical managers, and EID trainers (n = 51). The evaluation cohort comprised 707 HEI (67 HIV+). The baseline study cohort contained 1268 HEI (244 HIV+). Among infants testing HIV+, retention in care at an ART clinic increased from 23% (57/244) to 66% (44/67) (p < .0001). Initiation of HIV+ infants on ART increased from 36% (27/75) to 92% (46/50) (p < .0001). HEI receiving 1st PCR results increased from 57% (718/1268) to 73% (518/707) (p < .0001). Among breastfeeding HEI with negative 1st PCR, 55% (192/352) received a confirmatory PCR test, a substantial increase from baseline period. Testing coverage improved significantly: HIV+ pregnant women who brought their infants for testing after birth increased from 18% (67/367) to 52% (175/334) (p < .0001). HEI were tested younger: mean age at DBS test decreased from 6.96 to 4.21 months (p < .0001). Clinical care for HEI was provided more consistently. Implementation fidelity was strong for most program components. The strongest contributory interventions were establishment of 'EID Care Points', integration of clinical care, longitudinal patient tracking, and regular health worker mentorship. Gaps included limited follow up of lost infants, inconsistent buy-in/ownership of health facility management, and challenges sustaining health worker motivation. Uganda's 'EID Systems Strengthening' model has produced significant gains in testing and retention of HEI and HIV+ infants, yet the country still faces major challenges. The 3 core concepts of Uganda's model are applicable to any country: establish a central service point for HEI, equip it to provide high-quality care and tracking, and develop systems to link HEI to the service point. Uganda's experience has shown the importance of intensively targeting systemic bottlenecks to HEI retention at facility level, a necessary complement to deploying rapidly scalable technologies and other higher-level initiatives.
Identifiants
pubmed: 33539425
doi: 10.1371/journal.pone.0246546
pii: PONE-D-20-27234
pmc: PMC7861549
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0246546Déclaration de conflit d'intérêts
The authors declare they have no competing interests.
Références
PLoS One. 2013;8(2):e55308
pubmed: 23405133
AIDS. 2018 Jul 17;32(11):1453-1463
pubmed: 29746301
AIDS. 2009 Jan 2;23(1):101-6
pubmed: 19065753
N Engl J Med. 2008 Nov 20;359(21):2233-44
pubmed: 19020325
BMC Infect Dis. 2019 Sep 16;19(Suppl 1):783
pubmed: 31526371
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):522-526
pubmed: 28825941
PLoS One. 2017 Dec 20;12(12):e0189226
pubmed: 29261707
Lancet. 2003 Aug 16;362(9383):542
pubmed: 12932406
BMC Public Health. 2011 Jul 13;11:553
pubmed: 21749730
Lancet HIV. 2019 Jun;6(6):e373-e381
pubmed: 30987937
BMJ Open. 2019 Jul 29;9(7):e024907
pubmed: 31362959
J Acquir Immune Defic Syndr. 2020 Jul 1;84 Suppl 1:S12-S21
pubmed: 32520910
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219857724
pubmed: 31258023
J Acquir Immune Defic Syndr. 2020 Jul 1;84 Suppl 1:S1-S4
pubmed: 32520908
Clin Infect Dis. 2018 Aug 16;67(5):701-707
pubmed: 29490026
J Public Health Policy. 2015 May;36(2):153-69
pubmed: 25811386
Lancet. 2004 Oct 2-8;364(9441):1236-43
pubmed: 15464184
BMC Health Serv Res. 2017 Jan 18;17(1):48
pubmed: 28100207
J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):308-314
pubmed: 28418986
Pediatr Infect Dis J. 2008 Jan;27(1):22-6
pubmed: 18162933
Public Health Action. 2017 Jun 21;7(2):83-89
pubmed: 28695079
J Int AIDS Soc. 2010 Jan 20;13:3
pubmed: 20180975
Int J Qual Health Care. 2014 Dec;26(6):613-22
pubmed: 25335758
PLoS One. 2013 Nov 13;8(11):e78609
pubmed: 24236026
PLoS One. 2017 Dec 22;12(12):e0187605
pubmed: 29272268
AIDS. 2003 Apr 11;17(6):867-77
pubmed: 12660534
PLoS One. 2010 Nov 09;5(11):e13891
pubmed: 21085479
S Afr Med J. 2014 Mar;104(3 Suppl 1):239-43
pubmed: 24893500
AIDS. 2013 Nov;27 Suppl 2:S197-205
pubmed: 24361629
Lancet. 2003 Nov 15;362(9396):1605-11
pubmed: 14630440
J Clin Microbiol. 2012 Jul;50(7):2373-7
pubmed: 22518871
BMC Infect Dis. 2018 Aug 22;18(1):416
pubmed: 30134851
MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1285-1290
pubmed: 27880749
Health Policy Plan. 2014 Jul;29(4):495-505
pubmed: 23749734
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S51-S58
pubmed: 28398997
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):e68-76
pubmed: 27082507
PLoS One. 2014 Dec 29;9(12):e115171
pubmed: 25546453
AIDS. 2013 Nov;27 Suppl 2:S207-13
pubmed: 24361630
J Int AIDS Soc. 2018 Nov;21(11):e25209
pubmed: 30649834
BMC Med. 2011 May 20;9:59
pubmed: 21599888
J Int AIDS Soc. 2015 Dec 02;18(Suppl 6):20299
pubmed: 26639120